KCT0003487
Recruiting
未知
ong-term Safety of Entecavir and Tenofovir in Patients with Treatment-naïve Chronic Hepatitis B Virus (CHB) Infection (SAINT study) in real life setting
Hanyang University Seoul Hospital0 sites2,000 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hanyang University Seoul Hospital
- Enrollment
- 2000
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients aged 18 or older with CHB
- •2\. Patients with treatment\-naïve chronic hepatitis B virus (CHB) infection between 2012 and 2015 in the applicable hospital
- •(including interferon\-based treatment or oral antiviral agents within 3 months due to acute hepatitis B exacerbation)
- •3\. Patients with antiviral treatment for 6 months or over
Exclusion Criteria
- •1\. Patients with no initial treatment between 2012 and 2015 in the hospital
- •2\. Patients who have taken antiviral agents in another hospital
- •3\. Patients with chronic hepatitis C, HIV and coinfection
- •4\. Patients with history of hepatocellular carcinoma
- •5\. Patients diagnosed with malignant tumor(except hematologic malignancy) within 5 years prior to antiviral treatment
- •6\. Patient with insufficient data
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A Study of the Safety and Efficacy of Entecavir plus Tenofovir in Adults with Chronic Hepatitis B Virus Infection with Previous Nucleoside/Nucleotide Treatment Failure. - NDEUCTR2009-015705-40-ITBristol-Myers Squibb International Corporation125
Completed
Phase 3
Comparative study between Entecavir and Tenofovir in the treatment of chronic hepatitis B infection in Thai patientsChronic hepatitis B infectionChronic hepatitis B,Tenofovir,Entecavir,Efficacy,SafetyTCTR20180626002Chulabhorn Hospital442
Active, not recruiting
Not Applicable
Comparative Study of Entecavir vs Adefovir vs the Combination in Lamivudine- Refractory Chronic Hepatitis B Subjects The DEFINE Study Revised Protocol 01 - The DEFINE StudyEUCTR2006-000422-31-ITBristol-Myers Squibb International Corporation462
Completed
Phase 2
Clinical trial study on the therapeutic effect of Tenofovir besides routine drug regime (standard of care) in patients with Coronavirus disease 2019 (COVID-19)covid-19.Covid-19, confirmed cases, positive test resultU07.1IRCT20200422047168N1Ahvaz University of Medical Sciences60
Completed
Phase 4
Effectiveness and Safety of Tenofovir + Lamivudine + Efavirenz Generic Scheme for the Treatment of HIV Infection / AIDS in Patients of the CLS,Colombia, 2012-2013.HIV/AIDSRPCEC00000134Corporación de Lucha Contra el Sida80